Needle market forecast sees growth to $12.27 billion by 2030

The global needle market is projected to grow from $8.82 billion in 2025 to $9.5 billion in 2026, driven by vaccination, injectable therapies, chronic disease care and more clinical procedures. The Business Research Company says the market could reach $12.27 billion by 2030 as safety, disposable and self-injection products gain traction.

Why it matters: - Needle demand tracks core healthcare activity, including vaccinations, diagnostics, blood collection, injections and minor procedures. - Growth in ambulatory surgery, home care and diabetes treatment is pushing more use of disposable, safety and pen needles. - The market outlook points to continued spending across hospitals, outpatient centers and self-care settings.

What happened: - The Business Research Company projected the global needle market will rise from $8.82 billion in 2025 to $9.5 billion in 2026. - The forecast implies 7.7% growth in 2026. - The market is expected to reach $12.27 billion by 2030, at a 6.6% CAGR. - The report was published Aug. 19, 2026, from London. - The company also published a free sample and the full market report. - More information - The full report

The details: - Vaccine programs, injectable therapies, hospital and clinic procedure volumes, chronic disease prevalence and diagnostic testing demand are key near-term growth drivers. - Healthcare worker safety, home-based care, self-injection, diabetes growth, outpatient care expansion and minimally invasive procedures are shaping the longer-term outlook. - The report expects wider use of safety needles to reduce needle-stick injuries. - The report also expects stronger demand for disposable and single-use needles. - Pen needles for diabetes treatment are expected to see broader use. - Blood collection and diagnostics are becoming larger needle-use segments. - Sterile, pre-packaged needle products are gaining preference. - Needles are used for injections, blood sampling, fluid aspiration and tissue biopsies. - A needle typically includes a hollow tube and a hub that connects to syringes or other medical devices. - An Olympus America Inc. report published in July 2023 said U.S. ambulatory surgical centers increased from 6,109 in 2022 to 6,223 in 2023. - That report forecast 12% growth in U.S. ambulatory surgical centers over the next five years.

Between the lines: - The market is shifting toward lower-risk, more convenient products as care moves outside traditional hospitals. - The combination of outpatient expansion and self-administration favors needle formats that are easier to use and safer for staff and patients. - North America remains the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

What's next: - The Business Research Company expects market growth to continue through 2030 as outpatient care and home treatment expand. - Safety-focused product adoption is likely to remain a major theme. - The company says its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - The needle market is moving from a $9.5 billion market in 2026 toward $12.27 billion by 2030, with safety, self-care and outpatient care driving the next leg of growth.